Organisation paid for research Program year 2025 Source: CMS Open Payments

WCG Sonar Clinical Research

Neither a doctor nor a teaching hospital

Research payments

$328,318

2 payments

Through program year 2025, WCG Sonar Clinical Research is reported as receiving $328,318 in research payments, across 2 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2025	Research	$239,732	1
2024	Research	$88,586	1

Breakdown

Who paid Research payments · program years 2024–2025

Novartis Pharmaceuticals Corporation $328,318 2 payments

Studies the money was for Research payments · program years 2024–2025

A Phase III, Multicenter, Randomized, Placebo Controlled, Double-blind Study to Assess Efficacy and Safety of Crizanlizumab (5 mg/kg) Versus Placebo, With or Without Hydroxyurea/Hydroxycarbamide Therapy, in Adolescent and Adult Sickle Cell Disease Patient $239,732 1 payment
A Phase III, Multicenter, Randomized, Placebo Controlled, Double-blind Study to Assess Efficacy and Safety of Crizanlizumab (5 mg/kg) Versus Placebo, With or Without Hydroxyurea/Hydroxycarbamide Therapy, in Adolescent and Adult Sickle Cell Disease Patients With Frequent Vaso-Occlusive Crises $88,586 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.